Literature DB >> 27766382

[Cervical cancer : Update on morphology].

L-C Horn1, C E Brambs2, R Handzel3, S Lax4, I Sändig5, D Schmidt6, K Schierle5.   

Abstract

The World Health Organization (WHO) classification from 2014 differentiates between different subtypes of mucinous adenocarcinoma of the uterine cervix. A gastric subtype was recently described that showed no association with high-risk human papillomavirus (HPV) infections, has a poor prognosis, is mainly diagnosed in women of Asian origin and can occur in patients with Peutz-Jeghers syndrome. Although no clear grading system has been recommended in the WHO classification, it is likely that grading of adenocarcinomas of the uterine cervix will partly be based on the different patterns of invasion. Deep stromal infiltration of macroinvasive carcinomas is defined as an infiltration of >66 % of the cervical stroma. In the near future a maximum tumor size of 2 cm could act as a discriminator for planning of less radical surgery. Parameters of the histopathological report that are relevant for the prognostic assessment as well as the choice of adjuvant treatment and function as quality indicators during certification are described. The histological type of an adenocarcinoma alone is of no predictive or prognostic relevance for patients undergoing primary surgical treatment, neoadjuvant chemotherapy, combined chemo-radiotherapy or treatment with angiogenesis inhibitors. Currently, molecular parameters and biomarkers are of no relevance.

Entities:  

Keywords:  Adenocarcinoma; Biomarkers; Grading; Molecular pathology; Quality indicators

Mesh:

Substances:

Year:  2016        PMID: 27766382     DOI: 10.1007/s00292-016-0232-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  41 in total

1.  Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation.

Authors:  Peter G Rose; James J Java; Charles W Whitney; Frederick B Stehman; Rachelle Lanciano; Gillian M Thomas
Journal:  Gynecol Oncol       Date:  2014-08-23       Impact factor: 5.482

2.  Pattern of invasion is of prognostic value in surgically treated cervical cancer patients.

Authors:  L-C Horn; U Fischer; G Raptis; K Bilek; B Hentschel; C E Richter; U-D Braumann; J Einenkel
Journal:  Gynecol Oncol       Date:  2006-07-28       Impact factor: 5.482

3.  [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Authors:  L-C Horn; M W Beckmann; M Follmann; M C Koch; P Mallmann; S Marnitz; D Schmidt
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

4.  Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy.

Authors:  Michael Höckel; Lars-Christian Horn; Elisabeth Tetsch; Jens Einenkel
Journal:  Gynecol Oncol       Date:  2011-12-08       Impact factor: 5.482

5.  Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.

Authors:  Yasuki Kusanagi; Atsumi Kojima; Yoshiki Mikami; Takako Kiyokawa; Tamotsu Sudo; Satoshi Yamaguchi; Ryuichiro Nishimura
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

6.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

Authors:  Silvia de Sanjose; Wim Gv Quint; Laia Alemany; Daan T Geraets; Jo Ellen Klaustermeier; Belen Lloveras; Sara Tous; Ana Felix; Luis Eduardo Bravo; Hai-Rim Shin; Carlos S Vallejos; Patricia Alonso de Ruiz; Marcus Aurelho Lima; Nuria Guimera; Omar Clavero; Maria Alejo; Antonio Llombart-Bosch; Chou Cheng-Yang; Silvio Alejandro Tatti; Elena Kasamatsu; Ermina Iljazovic; Michael Odida; Rodrigo Prado; Muhieddine Seoud; Magdalena Grce; Alp Usubutun; Asha Jain; Gustavo Adolfo Hernandez Suarez; Luis Estuardo Lombardi; Aekunbiola Banjo; Clara Menéndez; Efrén Javier Domingo; Julio Velasco; Ashrafun Nessa; Saibua C Bunnag Chichareon; You Lin Qiao; Enrique Lerma; Suzanne M Garland; Toshiyuki Sasagawa; Annabelle Ferrera; Doudja Hammouda; Luciano Mariani; Adela Pelayo; Ivo Steiner; Esther Oliva; Chris Jlm Meijer; Waleed Fahad Al-Jassar; Eugenia Cruz; Thomas C Wright; Ana Puras; Cecilia Ladines Llave; Maria Tzardi; Theodoros Agorastos; Victoria Garcia-Barriola; Christine Clavel; Jaume Ordi; Miguel Andújar; Xavier Castellsagué; Gloria I Sánchez; Andrzej Marcin Nowakowski; Jacob Bornstein; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Oncol       Date:  2010-10-15       Impact factor: 41.316

7.  Dysregulation of CDK inhibitors and p53 in HPV-negative endocervical adenocarcinoma.

Authors:  Makiko Omori; Akihiko Hashi; Tetsuo Kondo; Ryohei Katoh; Shuji Hirata
Journal:  Int J Gynecol Pathol       Date:  2015-03       Impact factor: 2.762

8.  The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional study.

Authors:  Ira Winer; Isabel Alvarado-Cabrero; Oudai Hassan; Quratulain F Ahmed; Baraa Alosh; Sudeshna Bandyopadhyay; Sumi Thomas; Samet Albayrak; Shobhana Talukdar; Zaid Al-Wahab; Mohamed A Elshaikh; Adnan Munkarah; Robert Morris; Rouba Ali-Fehmi
Journal:  Gynecol Oncol       Date:  2015-02-10       Impact factor: 5.482

Review 9.  Cervical cancer: Biomarkers for diagnosis and treatment.

Authors:  Subramanyam Dasari; Rajendra Wudayagiri; Lokanatha Valluru
Journal:  Clin Chim Acta       Date:  2015-03-12       Impact factor: 3.786

10.  Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix.

Authors:  Chie Kuragaki; Takayuki Enomoto; Yuko Ueno; Hongbo Sun; Masami Fujita; Ryuichi Nakashima; Yutaka Ueda; Hiroko Wada; Yuji Murata; Toshihiko Toki; Ikuo Konishi; Shingo Fujii
Journal:  Lab Invest       Date:  2003-01       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.